Clinical Trial Update: LifeSeal™ Preliminary Study in Subjects Undergoing Low Anterior Resection [NA]

View source ↗

Summary

LifeBond Ltd.'s LifeSeal preliminary study in patients undergoing low anterior resection for rectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• LifeSeal

Snippet

Sponsor: LifeBond Ltd. | Conditions: Rectal Cancer | NA | Status: COMPLETED